Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Elicio Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 381 | $1.68K | $4.41 | Dec 16, 2024 | Direct |
Elicio Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 0 | Dec 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELTX | Elicio Therapeutics, Inc. | Dec 16, 2024 | 2 | $1.68K | 4 | Dec 18, 2024 | Chief Scientific Officer |
ELTX | Elicio Therapeutics, Inc. | Sep 30, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Chief Scientific Officer |
ELTX | Elicio Therapeutics, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | Chief Scientific Officer |
ELTX | Elicio Therapeutics, Inc. | Jun 1, 2023 | 0 | $0 | 3 | Jun 7, 2023 | Chief Scientific Officer |